Earnings Ahead

IDXX - IDEXX Laboratories, Inc.

484.2 2.38 0.49

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

About

Profile

Listed on NASDAQ since 1991 and a member of the S&P 500®, IDEXX Laboratories, Inc. (IDXX) is the global leader in veterinary diagnostics, software, and water microbiology testing.


Headquarters

Westbrook, Maine, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

IDXX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • IDEXX Laboratories beats top-line and bottom-line estimates; initiates FY24 outlook
  • IDEXX Laboratories Q4 2023 Earnings Preview
  • Piper Sandler downgrades Idexx to neutral, cites macro headwinds
  • AMZN, WDC and others could see post-earnings boost - Morgan Stanley's Mike Wilson
  • Top high-quality growth stocks poised to outperform - MS
  • Goldman Sachs 2024 stock strategy - sales growth
  • Goldman Sachs 2024 stock strategy - high quality
  • IDEXX Labs slips after cutting full year revenue guidance, sees softness in clinic visits
  • IDEXX Laboratories GAAP EPS of $2.53 beats by $0.16, revenue of $916M misses by $11.31M
  • IDEXX Laboratories Q3 2023 Earnings Preview
  • First U.S. bird flu case detected from commercial farm since April
  • IDEXX Laboratories Non-GAAP EPS of $2.70 beats by $0.23, revenue of $943.63M beats by $9.58M
  • IDEXX Laboratories Q2 2023 Earnings Preview
  • IDEXX Laboratories beats Q1 estimates on top and bottom line, increases outlook
  • IDEXX Laboratories Q1 2023 Earnings Preview
  • China reports world’s first human death due to H3N8 bird flu – WHO
  • IDEXX Laboratories Non-GAAP EPS of $2.07 beats by $0.15, revenue of $828.57M beats by $7.66M, initiates 2023 guidance
  • U.S. avian flu outbreak worst in history
  • IDEXX Laboratories rises on Q3 beat, narrows FY22 outlook on forex impact
  • IDEXX Laboratories Non-GAAP EPS of $2.23 beats by $0.19, revenue of $841.66M beats by $11.66M
Date Price Open High Low Vol Change
Dec 2 732.73 732.4
738.33
722.29
761K 0.52%
Dec 1 728.97 741.57
746.77
727.15
805K -3.18%
Nov 28 752.88 756.02
757.23
748
209K -0.41%
Nov 26 755.96 767.81
769.98
753.61
426K -1.4%
Nov 25 766.68 751.75
769.24
750.36
661K 1.93%
 
Nov 24 752.14 733.05
759.33
726.81
1.3M 3.61%
Nov 21 725.91 690.1
735.59
688.14
973K 5.30%
Nov 20 689.35 697.82
710.72
688.48
768K -1.11%
Nov 19 697.1 673.75
701.74
670.21
1.0M 4.01%
Nov 18 670.21 670.18
681.63
665.25
575K 0.18%
Nov 17 669 689.93
697.92
666.97
496K -3.03%
Nov 14 689.93 695.92
699.66
688.66
469K -1.65%
Nov 13 701.48 709.83
715.89
698.18
473K -1.69%
Nov 12 713.56 712.47
719.25
707.53
469K 0.15%
Nov 11 712.47 710.94
718.52
709.09
292K 0.41%
Nov 10 709.59 708.06
713.03
699.84
352K 0.16%
Nov 7 708.45 710.15
716.71
700.2
410K -0.74%
Nov 6 713.74 712.47
720
694
1.1M -0.9%
Nov 5 720.21 724.36
728.95
701.61
591K -0.26%
Nov 4 722.12 717.44
726.5
706.59
681K -0.11%
Nov 3 722.94 693
735
691.73
1.7M 14.84%
Oct 31 629.51 634.51
641.29
628.9
974K 0.15%
Oct 30 628.54 627.66
632.94
626.87
373K 0.14%
Oct 29 627.66 635.41
635.41
622.08
490K -1.06%
Oct 28 634.36 640.53
646
633.18
397K -2.01%
Oct 27 647.4 644.46
649.07
639.11
453K 1.02%
Oct 24 640.85 641.76
650.37
639.08
368K 0.35%
Oct 23 638.6 631.25
641.47
630.7
533K 0.76%
Oct 22 633.78 642.41
642.41
628.6
465K -0.53%
Oct 21 637.13 641.64
643
630.49
408K -0.98%
Oct 20 643.41 638.2
644.92
634.91
327K 1.26%
Oct 17 635.4 633.88
637.48
627.43
277K -0.3%
Oct 16 637.34 643.44
651.5
628.17
525K -0.28%
Oct 15 639.15 640.2
642.91
631.78
387K 0.35%
Oct 14 636.91 625.66
642.59
625.61
365K 0.57%
Oct 13 633.32 622.66
634.28
621.83
377K 2.79%
Oct 10 616.15 628.75
628.75
615
411K -2%
Oct 9 628.75 624.59
631.79
619.95
385K -0.18%
Oct 8 629.91 634.3
638.63
626.11
521K 0.42%
Oct 7 627.28 639.11
639.11
622.15
320K -0.08%
Oct 6 627.78 633.56
634.15
626.19
248K -0.54%
Oct 3 631.19 637.01
642.25
627.97
339K -0.42%
Oct 2 633.84 616.52
634.87
614.55
416K 2.21%
Oct 1 620.11 630.72
638.24
600.57
660K -2.94%
Sep 30 638.89 631.27
639.53
629.67
367K 1.32%
Sep 29 630.56 636.34
636.34
619
266K -0.26%
Sep 26 632.22 619.31
636
615.33
344K 2.27%
Sep 25 618.17 620.93
621.13
613.28
380K -1.44%
Sep 24 627.17 645.12
645.12
621.36
464K -3.27%
Sep 23 648.38 640.34
649.47
640.34
351K 0.66%
Sep 22 644.1 653.17
657.11
640.28
387K -1.84%
Sep 19 656.16 659.58
661.39
648.84
982K 0.10%
Sep 18 655.51 642.53
659.17
635.94
474K 2.29%
Sep 17 640.86 644.59
651.05
637
445K -0.74%
Sep 16 645.65 640.37
648.32
635.5
404K 0.26%
Sep 15 643.99 641.73
651.33
641.73
455K 0.44%
Sep 12 641.14 639.24
644.86
625.55
318K -0.62%
Sep 11 645.16 637.14
648.29
637.14
337K 1.13%
Sep 10 637.95 652.91
653.67
631.74
389K -2.69%
Sep 9 655.6 652.83
655.77
647.78
272K 0%